RNF12 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant RNF12.
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB, IF, IP, E |
---|---|
Primary Accession | Q9NVW2 |
Other Accession | NM_016120 |
Reactivity | Human |
Host | Mouse |
Clonality | monoclonal |
Isotype | IgG2a Kappa |
Clone Names | 1G10 |
Calculated MW | 68549 Da |
Gene ID | 51132 |
---|---|
Other Names | E3 ubiquitin-protein ligase RLIM, 632-, LIM domain-interacting RING finger protein, RING finger LIM domain-binding protein, R-LIM, RING finger protein 12, Renal carcinoma antigen NY-REN-43, RLIM, RNF12 |
Target/Specificity | RNF12 (NP_057204, 1 a.a. ~ 83 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IF~~1:50~200 IP~~N/A E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | RNF12 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene is a RING-H2 zinc finger protein. It has been shown to be an E3 ubiquitin protein ligase that targets LIM domain binding 1 (LDB1/CLIM), and causes proteasome-dependent degradation of LDB1. This protein and LDB1 are co-repressors of LHX1/LIM-1, a homeodomain transcription factor. Multiple alternatively spliced variants, encoding the same protein, have been identified.
REFERENCES
1.Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling.Zhou F, Drabsch Y, Dekker TJ, de Vinuesa AG, Li Y, Hawinkels LJ, Sheppard KA, Goumans MJ, Luwor RB, de Vries CJ, Mesker WE, Tollenaar RA, Devilee P, Lu CX, Zhu H, Zhang L, Dijke PTNat Commun. 2014 Mar 3;5:3388. doi: 10.1038/ncomms4388.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.